Treating IgG4-related disease with rituximab r185a

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in...

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients after treatment. They discuss the potential implications for future treatment, drawbacks of the study and possible future research directions for the disease.

Dr Steven Zhao on comorbidities and disease activity in axSpA 10 días 07:54 Dr Gouri Koduri on patient perceptions of comorbidities +1 año 11:54 Dr Edward Roddy on the recently conducted gout audit +1 año 02:51 Dr David Fajgenbaum on cytokine storm syndromes +1 año 11:15 Results from the NEIAA Short Report on Ethnicity +1 año 18:43 Ver más en APP Comentarios del episodio 5t5a3n